Medxtractor Doubles Down on B2B Licensing & mHealth
Cannabis Law Report
AUGUST 3, 2021
The company’s initial focus is on predicting the potential benefits of psychedelic drugs on various mental health conditions and developing an mHealth consumer health application, called YMI, to predict an individual’s current and future mental and physical health conditions. compound annual growth rate from $2.8
Let's personalize your content